Proximal small intestinal mucosal injury. Maintenance of glucose and glucose polymer absorption, attenuation of disaccharide absorption.
The effect of chronic intragastric infusion of hypertonic mannitol on small intestinal mucosal structure and function was studied in adult rats. Animals were gavage-fed 20% mannitol (1300 mosm) at a dose of 5 ml/100 g body weight daily for seven days. Control animals were gavage-fed tap water on the same schedule. On day 8, the animals were anesthetized, the duodenum cannulated, and a test sugar (glucose, glucose polymer, lactose, sucrose, or maltose) was infused at a dose of 0.5 g/kg body weight in 2.5 ml distilled water over less than 1 min. Portal vein glucose was measured at 30-min intervals from 0 to 120 min. Mannitol treatment resulted in histologic and biochemical alterations (reduced lactase, sucrase, maltase) limited to the proximal small intestine compared to the control group. The absorption of glucose and glucose polymers was similar in mannitol-treated and control animals. In contrast, digestion and absorption of lactose, sucrose, and maltose was significantly diminished in mannitol-treated animals when compared to controls. No changes in permeability to polyethylene glycol 4000 or Na+-coupled glucose transport were observed in mannitol-treated animals compared to controls. These data suggest that when the intestinal mucosa is exposed to hyperosmolar loads that the digestive capacity for disaccharides is suppressed more than its glucose absorptive capacities. Furthermore, glucose oligomers may be more readily digested and absorbed than disaccharides, in this setting, due, in part, to the proximal injury and less pronounced proximal-distal gradient for glucoamylase than other brush-border carbohydrases.(ABSTRACT TRUNCATED AT 250 WORDS)
Palacios
M
M
International Institute for Infant Nutrition and Gastrointestinal Disease, Children's Hospital of Buffalo.
Madariaga
H
H
Heitlinger
L
L
Lee
P C
PC
Lebenthal
E
E
D000818:Animals; D001692:Biological Transport; D003967:Diarrhea / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D004187:Disaccharides / Q000378:metabolism*; D005936:Glucans / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D007408:Intestinal Absorption / Q000187:drug effects; D007413:Intestinal Mucosa / Q000378:metabolism / Q000473:pathology; D007421:Intestine, Small / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D007785:Lactose / Q000378:metabolism; D008320:Maltose / Q000378:metabolism; D008353:Mannitol / Q000494:pharmacology; D010539:Permeability; D011092:Polyethylene Glycols / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013395:Sucrose / Q000378:metabolism
D004187:Disaccharides; D005936:Glucans; D008353:Mannitol; D011092:Polyethylene Glycols; D013395:Sucrose; D008320:Maltose; D005947:Glucose; D007785:Lactose